Agan, Cheryl A.
HRN: 07-02-31 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/09/2022
CEFUROXIME 500MG (TAB)
04/09/2022
04/15/2022
IV
500mg
BID
S/P NSUD With Repair Of 2nd Degree Laceration
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: No Wrong Route Wrong Route
Overall appropriateness: No Wrong Route